½ÃÀ庸°í¼­
»óǰÄÚµå
1090107

¼¼°èÀÇ Æ÷½ºÄݸ° ½ÃÀå ±Ô¸ð : ³óµµ, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº° ¿¹Ãø(2022-2028³â)

Global Forskolin Market Size study, By Concentration (Low Concentration, Medium Concentration, High Concentration ), By Application, By End Use, and Regional Forecasts 2022-2028

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ÉÇ÷°üÁúȯ ºÎ´ãÁõ°¡, ´ºÆ®¶ó½´Æ¼Äà ¼ö¿ä È®´ë, °í·ÉÀÚ Àα¸ ±ÞÁõÀÌ ¼¼°è ½ÃÀå ¼ö¿ä¸¦ ³ôÀ̰í ÀÖ´Â ¿äÀÎÀÔ´Ï´Ù.

»ýȰ½À°üº´ È®´ë¿Í õ¿¬ °Ç°­ º¸Á¶ ½Äǰ ¼ö¿ä Áõ°¡°¡ ¿¹Ãø ±â°£¿¡ ½ÃÀå ¼ö¿ä¸¦ ÀÚ±ØÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±×·¯³ª, °íºñ¿ë, ´ëüǰÀÇ °¡¿ë¼º, Æ÷½ºÄݸ° ¼·Ãë¿¡ °ü·ÃµÈ ºÎÀÛ¿ëÀÌ 2022-2028³â°£ ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ Æ÷½ºÄݸ°(Forskolin) ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, ½ÃÀå µ¿Çâ, °æÀï ±¸µµ, ºÎ¹®º°¡¤Áö¿ªº° ½ÃÀå ºÐ¼®, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ¼¼°èÀÇ Æ÷½ºÄݸ° ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

Á¦3Àå ¼¼°èÀÇ Æ÷½ºÄݸ° ½ÃÀå ¿ªÇÐ

  • Æ÷½ºÄݸ° ½ÃÀå ¿µÇ⠺м®(2020-2028³â)

Á¦4Àå ¼¼°èÀÇ Æ÷½ºÄݸ° ½ÃÀå ¾÷°è ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
  • PEST ºÐ¼®
  • ÅõÀÚ Ã¤¿ë ¸ðµ¨
  • ¾Ö³Î¸®½ºÆ®ÀÇ Ãßõ »çÇ×°ú °á·Ð
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«

Á¦5Àå ¸®½ºÅ© Æò°¡ : COVID-19ÀÇ ¿µÇâ

    • ¾÷°è¿¡ ´ëÇÑ COVID-19ÀÇ ÀüüÀûÀÎ ¿µÇâ Æò°¡
    • COVID-19 ÀÌÀü ¹× COVID-19 ÀÌÈÄÀÇ ½ÃÀå ½Ã³ª¸®¿À

Á¦6Àå ¼¼°èÀÇ Æ÷½ºÄݸ° ½ÃÀå : ³óµµº°

  • ½ÃÀå ÇöȲ
  • ½ÃÀå ½ÇÀû ¹× °¡´É¼º ºÐ¼® : ³óµµº°
  • ½ÃÀå Ãß»ê°ú ¿¹Ãø : ³óµµº°(2018-2028³â)
  • ÇÏÀ§ ºÎ¹® ºÐ¼®
    • Àú³óµµ(10%)
    • Áß³óµµ(20-40%)
    • °í³óµµ(95%)

Á¦7Àå ¼¼°èÀÇ Æ÷½ºÄݸ° ½ÃÀå : ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • ½ÃÀå ½ÇÀû ¹× °¡´É¼º ºÐ¼® : ¿ëµµº°
  • ½ÃÀå Ãß»ê°ú ¿¹Ãø : ¿ëµµº°(2018-2028³â)
  • ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ¾Ë·¹¸£±â Ä¡·á
    • üÁß °ü¸®
    • È£Èí±â Áúȯ
    • ½ÉÇ÷°ü Àå¾Ö
    • ³ì³»Àå
    • °©»ó¼± ±â´É ÀúÇÏÁõ
    • °Ç¼±
    • ±âŸ

Á¦8Àå ¼¼°èÀÇ Æ÷½ºÄݸ° ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå ÇöȲ
  • ½ÃÀå ½ÇÀû ¹× °¡´É¼º ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°
  • ½ÃÀå Ãß»ê°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°(2018-2028³â)
  • ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ´ºÆ®¶ó½´Æ¼ÄÃ
    • Á¦¾à
    • °Ç°­º¸Á¶½Äǰ
    • ½Äǰ°¡°ø
    • È­Àåǰ
    • ±âŸ

Á¦9Àå ¼¼°èÀÇ Æ÷½ºÄݸ° ½ÃÀå : Áö¿ª ºÐ¼®

  • Áö¿ª ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • ±âŸ Áö¿ª

Á¦10Àå °æÀï Á¤º¸

  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Nutra Green Biotechnology Co., Ltd.
    • Cymbio Pharma Pvt. Ltd.
    • Bioprex Labs
    • Sabinsa Corporation
    • Wolfson Berg Limited
    • Varion Lifesciences Pvt. Ltd.
    • Alchem International Limited
    • Flavour trove
    • Alexa Biotech Pvt. Ltd.
    • Shaanxi Jiahe Phytochem

Á¦11Àå Á¶»ç ÇÁ·Î¼¼½º

LSH 22.07.08

Global Forskolin Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. The Forskolin refers to an active compound derived from the roots of the Indian coleus (Coleus forskohlii), a tropical plant related to mint. The plant mainly grows in Nepal, India, and Thailand. Forskolin. Forskolin has application in treatment of obesity, glaucoma, allergies and asthma, heart failure, and intestinal spasms among others. The rising burden of cardiovascular diseases and increasing demand for dietary supplements as well as surging population of geriatric population are factors that are accelerating the global market demand. For instance, according to World Health Organization (WHO)- as of 2019, around 17.9 million people lost their lives due to cardiovascular diseases (CVDs), witnessing 32% of all global deaths. Furthermore, as per United Nations estimates - In 2019, there were around 703 million persons aged 65 years or over in the world. The number of older persons is projected to double to 1.5 billion in 2050. Also, growing prevalence of lifestyle diseases and increasing demand for natural dietary supplements are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, high cost and availability of substitute and side effects associated with consumption of forskolin impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Forskolin Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Asia-Pacific is the leading region across the world in terms of market share owing to the growing prevalence of lifestyle diseases and wide availability of raw materials. Whereas, North America is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as increasing incidences of cardiovascular disease and growing demand for plant based health supplements in the region, would create lucrative growth prospects for the global Forskolin Market across the North America region.

Major market players included in this report are:

Nutra Green Biotechnology Co., Ltd.

Cymbio Pharma Pvt. Ltd.

Bioprex Labs

Sabinsa Corporation

Wolfson Berg Limited

Varion Lifesciences Pvt. Ltd.

Alchem International Limited

Flavour trove

Alexa Biotech Pvt. Ltd.

Shaanxi Jiahe Phytochem

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Concentration:

Low Concentration (10%)

Medium Concentration (20% to 40%)

High Concentration (95%)

By Application:

Allergy Treatment

Weight Management

Respiratory Problems

Cardiovascular Disorders

Glaucoma

Hypothyroidism

Psoriasis

Others

By End Use:

Nutraceuticals

Pharmaceutical

Dietary Supplements

Food Processing

Cosmetics

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Forskolin Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Global Forskolin Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Global Forskolin Market, by Concentration, 2020-2028 (USD Million)
    • 1.2.3. Global Forskolin Market, by Application, 2020-2028 (USD Million)
    • 1.2.4. Global Forskolin Market, by End Use, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Forskolin Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Forskolin Market Dynamics

  • 3.1. Forskolin Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising burden of cardiovascular diseases
      • 3.1.1.2. Increasing demand for dietary supplements
      • 3.1.1.3. Surging population of geriatric population.
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost and availability of substitute
      • 3.1.2.2. Side effects associated with consumption of forskolin
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing prevalence of lifestyle diseases.
      • 3.1.3.2. Increasing demand for natural dietary supplements.

Chapter 4. Global Forskolin Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Forskolin Market, by Concentration

  • 6.1. Market Snapshot
  • 6.2. Global Forskolin Market by Concentration, Performance - Potential Analysis
  • 6.3. Global Forskolin Market Estimates & Forecasts by Concentration 2018-2028 (USD Million)
  • 6.4. Forskolin Market, Sub Segment Analysis
    • 6.4.1. Low Concentration (10%)
    • 6.4.2. Medium Concentration (20% to 40%)
    • 6.4.3. High Concentration (95%)

Chapter 7. Global Forskolin Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Forskolin Market by Application, Performance - Potential Analysis
  • 7.3. Global Forskolin Market Estimates & Forecasts by Application 2018-2028 (USD Million)
  • 7.4. Forskolin Market, Sub Segment Analysis
    • 7.4.1. Allergy Treatment
    • 7.4.2. Weight Management
    • 7.4.3. Respiratory Problems
    • 7.4.4. Cardiovascular Disorders
    • 7.4.5. Glaucoma
    • 7.4.6. Hypothyroidism
    • 7.4.7. Psoriasis
    • 7.4.8. Others

Chapter 8. Global Forskolin Market, by End Use

  • 8.1. Market Snapshot
  • 8.2. Global Forskolin Market by End Use, Performance - Potential Analysis
  • 8.3. Global Forskolin Market Estimates & Forecasts by End Use 2018-2028 (USD Million)
  • 8.4. Forskolin Market, Sub Segment Analysis
    • 8.4.1. Nutraceuticals
    • 8.4.2. Pharmaceutical
    • 8.4.3. Dietary Supplements
    • 8.4.4. Food Processing
    • 8.4.5. Cosmetics
    • 8.4.6. Others

Chapter 9. Global Forskolin Market, Regional Analysis

  • 9.1. Forskolin Market, Regional Market Snapshot
  • 9.2. North America Forskolin Market
    • 9.2.1. U.S. Forskolin Market
      • 9.2.1.1. Concentration estimates & forecasts, 2018-2028
      • 9.2.1.2. Application estimates & forecasts, 2018-2028
      • 9.2.1.3. End Use estimates & forecasts, 2018-2028
    • 9.2.2. Canada Forskolin Market
  • 9.3. Europe Forskolin Market Snapshot
    • 9.3.1. U.K. Forskolin Market
    • 9.3.2. Germany Forskolin Market
    • 9.3.3. France Forskolin Market
    • 9.3.4. Spain Forskolin Market
    • 9.3.5. Italy Forskolin Market
    • 9.3.6. Rest of Europe Forskolin Market
  • 9.4. Asia-Pacific Forskolin Market Snapshot
    • 9.4.1. China Forskolin Market
    • 9.4.2. India Forskolin Market
    • 9.4.3. Japan Forskolin Market
    • 9.4.4. Australia Forskolin Market
    • 9.4.5. South Korea Forskolin Market
    • 9.4.6. Rest of Asia Pacific Forskolin Market
  • 9.5. Latin America Forskolin Market Snapshot
    • 9.5.1. Brazil Forskolin Market
    • 9.5.2. Mexico Forskolin Market
  • 9.6. Rest of The World Forskolin Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Nutra Green Biotechnology Co., Ltd.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Cymbio Pharma Pvt. Ltd.
    • 10.2.3. Bioprex Labs
    • 10.2.4. Sabinsa Corporation
    • 10.2.5. Wolfson Berg Limited
    • 10.2.6. Varion Lifesciences Pvt. Ltd.
    • 10.2.7. Alchem International Limited
    • 10.2.8. Flavour trove
    • 10.2.9. Alexa Biotech Pvt. Ltd.
    • 10.2.10. Shaanxi Jiahe Phytochem

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦